These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 12539070

  • 1. Isoniazid hepatotoxicity among drug users: the role of hepatitis C.
    Fernández-Villar A, Sopeña B, Vázquez R, Ulloa F, Fluiters E, Mosteiro M, Martínez-Vázquez C, Piñeiro L.
    Clin Infect Dis; 2003 Feb 01; 36(3):293-8. PubMed ID: 12539070
    [Abstract] [Full Text] [Related]

  • 2. Isoniazid hepatotoxicity in renal transplant recipients.
    Antony SJ, Ynares C, Dummer JS.
    Clin Transplant; 1997 Feb 01; 11(1):34-7. PubMed ID: 9067692
    [Abstract] [Full Text] [Related]

  • 3. Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy.
    Vikrant S, Agarwal SK, Gupta S, Bhowmik D, Tiwari SC, Dash SC, Guleria S, Mehta SN.
    Transpl Infect Dis; 2005 Feb 01; 7(3-4):99-108. PubMed ID: 16390397
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Safety of treatment of latent tuberculosis infection in compensated cirrhotic patients during transplant candidacy period.
    Jahng AW, Tran T, Bui L, Joyner JL.
    Transplantation; 2007 Jun 27; 83(12):1557-62. PubMed ID: 17589337
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis.
    Gao XF, Wang L, Liu GJ, Wen J, Sun X, Xie Y, Li YP.
    Int J Tuberc Lung Dis; 2006 Oct 27; 10(10):1080-90. PubMed ID: 17044199
    [Abstract] [Full Text] [Related]

  • 12. Absence of transaminase elevation during concomitant methotrexate and isoniazid therapy.
    Ekochin LH, Manadan AM, Aggarwal R, Sequeira W, Block JA.
    J Rheumatol; 2009 Sep 27; 36(9):2127. PubMed ID: 19738229
    [No Abstract] [Full Text] [Related]

  • 13. Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs.
    Scholten JN, Driver CR, Munsiff SS, Kaye K, Rubino MA, Gourevitch MN, Trim C, Amofa J, Seewald R, Highley E, Fujiwara PI.
    Clin Infect Dis; 2003 Dec 15; 37(12):1686-92. PubMed ID: 14689352
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Incidence of statin hepatotoxicity in patients with hepatitis C.
    Khorashadi S, Hasson NK, Cheung RC.
    Clin Gastroenterol Hepatol; 2006 Jul 15; 4(7):902-7; quiz 806. PubMed ID: 16697272
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Isoniazid-monoresistant tuberculosis in the United States, 1993 to 2003.
    Hoopes AJ, Kammerer JS, Harrington TA, Ijaz K, Armstrong LR.
    Arch Intern Med; 2008 Oct 13; 168(18):1984-92. PubMed ID: 18852399
    [Abstract] [Full Text] [Related]

  • 19. Isoniazid-related hepatic failure in children: a survey of liver transplantation centers.
    Wu SS, Chao CS, Vargas JH, Sharp HL, Martín MG, McDiarmid SV, Sinatra FR, Ament ME.
    Transplantation; 2007 Jul 27; 84(2):173-9. PubMed ID: 17667808
    [Abstract] [Full Text] [Related]

  • 20. Tolerability of anti-tuberculosis treatment and HIV serostatus.
    Lanternier F, Dalban C, Perez L, Bricaire F, Costagliola D, Caumes E.
    Int J Tuberc Lung Dis; 2007 Nov 27; 11(11):1203-9. PubMed ID: 17958982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.